Skip to content
Review

Biotechnological Strategies for Enhanced Secondary Metabolite Production in Medicinal Plants: A Comparative Review

Oct 2026 · Current Chemical Biology · 0 citations

Abstract

Medicinal plants are vital sources of high-value secondary metabolites, alkaloids, terpenoids, flavonoids, and phenolics for pharmaceutical, nutraceutical, and cosmeceutical use, but conventional field extraction suffers from low yields, seasonal variation, and unsustainable wild harvesting. This review compares four biotechnological strategies, tissue culture, elicitation, metabolic engineering, and CRISPR-based genome editing, for their efficacy, scalability, cost, regulatory burden, and commercial applicability in enhancing secondary metabolite production. This work is a narrative review. A structured literature search of Scopus (Elsevier), conducted on 6 May 2026, combined terms for secondary metabolites with tissue culture, hairy root, elicitation, metabolic engineering, CRISPR/genome editing, and biosynthesis pathways; 183 records were retrieved, and 72 peer-reviewed articles (2003–2026) met inclusion criteria after deduplication and screening. Tissue culture offers the highest scalability and bioreactor readiness; elicitation gives rapid, low-cost yield gains (3–10-fold); metabolic engineering enables stable, heritable pathway redirection (2–12-fold); and CRISPR-based tools achieve the greatest precision and fold-change (5–40- fold). Case studies across seven model species illustrate 2–40-fold compound improvements. These platforms differ chiefly in scalability versus precision and in regulatory burden, and no single approach is universally optimal; rather, platform choice should be matched to the target metabolite, plant species, and commercial context. Combining approaches, particularly elicitation with engineered or edited lines, mitigates the individual limitations of transience, cost, and yield instability. Integrative strategies combining CRISPR-mediated pathway activation with elicitation in optimized tissue culture systems represent the most promising frontier for scalable, sustainable production of plant bioactive compounds.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.